FR EN

Back


10/12/2019
PRESS RELEASE - Idinvest Partners finances Keensight Capital's acquisition of 3P Biopharmaceuticals
Idinvest Partners, a leading investor in SMEs across Europe, has arranged the unitranche financing of Keensight Capital's acquisition of 3P Biopharmaceuticals. It is the 8th deal closed this year by Idinvest's Private Debt team in the Iberian Peninsula.

Download the pdf file





X

X

X